Renal Sympathetic Denervation as a Treatment for Atrial Fibrillation

Renal Sympathetic Denervation as a Treatment for Atrial Fibrillation
Renal Sympathetic Denervation as a Treatment for Atrial Fibrillation
204621

Number of Participants

300

Eligibility

The patient must be having an ablation procedure for atrial fibrillation. The patient must have a history of significant hypertension and be receiving treatment with at least one anti-hypertensive medication.

Purpose

The purpose of this study is to find out if renal sympathetic denervation performed at the same time as a radiofrequency ablation procedure for atrial fibrillation will result in less recurrences of atrial fibrillation.

Treatment

The patient will be randomized (like flipping a coin) to the atrial fibrillation ablation alone group versus the atrial fibrillation ablation plus renal sympathetic denervation group.

Principal Investigator

David J. Wilber

M.D., FAHA, FACC
Cardiology
George M. Eisenberg Professor of Cardiovascular Sciences

Enrollment

(708) 216-2644

More Clinical Trials

See Also

© 2011 Loyola University Chicago Health Sciences Division. All rights reserved.  &npsp; Privacy Policy   Privacy Policy